Epstein Secrets

f extensive correspondence (including IG Hoecker) clearly shows: the SEC/FINRA/FINCEN UBS AML EFTA00093911 complaint for which Norberg,Pasquinelli,Knowles,Wardlay issued their fraud denial WHILE I was still waiting for my Opco Denial appeal: The Opco trading data ALSO implicates UBS as well as NITE: S

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve

s the record of extensive correspondence (including IG Hoecker) clearly shows: the SEC/FINRA/FINCEN UBS AML complaint for which Norberg,Pasquinelli,Knowles,Wardlay issued their fraud denial WHILE I was still waiting for my Opco Denial appeal: The Opco trading data ALSO implicates UBS as well as NITE: S

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve

f extensive correspondence (including IG Hoecker) clearly shows: the SEC/FINRA/FINCEN UBS AML EFTA00072165 complaint for which Norberg,Pasquinelli,Knowles,Wardlay issued their fraud denial WHILE I was still waiting for my Opco Denial appeal: The Opco trading data ALSO implicates UBS as well as NITE: S

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve